100 Participants NeededMy employer runs this trial

Multimodal Analgesic Regimen for Postoperative Pain

AM
Overseen ByAntonio M Pellerito, BA
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores ways to manage pain after hip replacement surgery while reducing opioid use. Participants are divided into two groups: one follows a standard multimodal analgesic regimen with opioid prescriptions sent directly to their pharmacy, and the other follows an opioid-reduced regimen with a printed prescription, requiring them to decide whether to fill it. The researchers aim to determine if this approach can reduce opioid use without compromising pain relief. Individuals who have undergone total hip replacement surgery and lack a history of chronic pain or recent drug abuse might be suitable candidates. As an unphased trial, this study provides an opportunity to contribute to innovative pain management strategies that could benefit future patients.

Is there any evidence suggesting that this trial's treatments are likely to be safe?

Research has shown that multimodal pain management, which uses a mix of different pain relief methods, is generally safe and well-tolerated. These methods effectively manage pain and reduce the need for opioids. For example, one study found that patients using these methods after surgery required fewer opioids and experienced fewer complications.

This approach typically combines various medications and techniques, lowering the risk of side effects from high opioid use. Specifically, patients who underwent total hip replacements and used this method needed fewer opioids, indicating improved safety. By reducing opioid use, patients may experience fewer side effects like nausea or dizziness, which are common with opioid medications.

Overall, these findings suggest that multimodal pain management safely reduces opioid use and effectively manages pain after surgery.12345

Why are researchers excited about this trial?

Researchers are excited about this trial because it explores a new approach to managing postoperative pain with fewer opioids. Unlike the standard care where opioid prescriptions are automatically sent to the pharmacy, this method requires patients to actively decide to fill their opioid prescriptions by going to the pharmacy themselves. This could potentially reduce the patient's reliance on opioids and encourage the use of other pain management strategies. By comparing this opioid-reduced protocol with the traditional approach, researchers hope to find out if it can effectively manage pain while minimizing opioid use and its associated risks.

What evidence suggests that this trial's treatments could be effective for managing postoperative pain after hip replacement surgery?

Research has shown that combining different pain relief methods can effectively reduce the need for opioids after surgery. In this trial, participants will join one of two treatment arms. The Opioid-Reduced Postoperative Pain Protocol arm uses a multimodal analgesic regimen with printed opioid prescriptions, requiring patients to actively choose to fill them. Studies have found that this approach can lower opioid use by 10% to 40% without increasing pain levels. For instance, one study reported a 35.4% reduction in opioids prescribed during recovery. Non-opioid options like NSAIDs (a type of anti-inflammatory drug) and COX-2 inhibitors prove particularly effective. Overall, this combined approach provides effective pain relief while reducing opioid use.678910

Who Is on the Research Team?

MC

Michael Charters, MD

Principal Investigator

Henry Ford Health System

Are You a Good Fit for This Trial?

This trial is for adults having total hip replacement surgery. Participants must be able to keep a pain journal and attend follow-up visits. People who can't safely take the study medications or have conditions that would interfere with participation are excluded.

Inclusion Criteria

I am 18 years old or older.
I had a total hip replacement by one fellowship-trained orthopedic surgeon.

Exclusion Criteria

Patients with incomplete data in medical records
Intolerance to Tylenol, Celebrex, Robaxin, Neurontin, or Tramadol
History of Alcohol abuse
See 11 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo total hip replacement surgery and receive a multimodal analgesic regimen to manage postoperative pain

3 weeks
Daily visits during inpatient stay, weekly follow-ups for 2 weeks post-discharge

Follow-up

Participants are monitored for pain management, opioid use, and overall recovery through questionnaires and clinical assessments

Up to 3 months
Scheduled follow-up visits for assessments

What Are the Treatments Tested in This Trial?

Interventions

  • Opioid-Reduced Multimodal Analgesic Regimen with Printed Prescription
  • Standard Multimodal Analgesic Regimen with Opioid Prescription

Trial Overview

The study compares two ways of prescribing opioid painkillers after hip replacement: one group gets their prescription sent directly to the pharmacy, while the other receives a printed prescription they can choose to fill. Both groups use standard pain control methods.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Active Control

Group I: Opioid-Reduced Postoperative Pain Protocol (Treatment)Experimental Treatment1 Intervention
Group II: Standard Postoperative Pain Protocol (Control)Active Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Henry Ford Health System

Lead Sponsor

Trials
334
Recruited
2,197,000+

Citations

Implementation of a Post-Surgical, Multimodal Analgesia ...

Results from this study suggest the use of perioperative multimodal analgesia reduces opioid consumption without increasing pain scores. Future ...

Multimodal analgesia for postoperative pain

The use of these diverse methods of analgesia has been shown to reduce postoperative opioid consumption and provide pain relief [6].

Multimodal Pain Strategies Guide for Postoperative ...

A multimodal pain management strategy is one that employs both non-opioid and opioid pharmacologic regimens, as well as nonpharmacologic measures. This is ...

Multimodal Approach to Pain Management Reduces ...

NSAIDs and COX-2 inhibitors used in a multimodal regimen seemed to be the most effective modalities, with the greatest reduction in opioid ...

5.

pubmed.ncbi.nlm.nih.gov

pubmed.ncbi.nlm.nih.gov/37405552/

Rational Multimodal Analgesia for Perioperative Pain ...

A multimodal analgesic approach improves postoperative pain relief and reduces opioid use; however, it is not universally implemented.

New Multimodal Pain Management Strategy Slashes ...

This innovative strategy presents a safer alternative to traditional opioid-only regimens, effectively managing pain while addressing the opioid ...

A Study Evaluating the Effectiveness of Multimodal Pain ...

Some studies have shown that multimodal regimens are more beneficial than opioid-based interventions, resulting in reduced patient-reported pain ...

Multimodal Analgesia Reduces Opioids, Complications After ...

According to the article, total hip replacement patients who received more than two methods of pain relief along with opioids had up to an 18.5 ...

Comparison of an Opioid-Free Multimodal Pain Regimen ...

Overall, these results suggest that an opioid-free postoperative treatment regimen has similar effectiveness in controlling a patient's pain ...

Multimodal Pain Management Approach Decreases ...

A multimodal intervention resulted in decreased opioid dosages following surgical procedures among patients with high preoperative opioid use.